Agency Information Collection Activities; Proposed eCollection eComments Requested; Revision of a Previously Approved Collection; Application for Registration and Application for Registration Renewal; DEA Forms 224, 224A
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Issuing agencies
Abstract
The Department of Justice (DOJ), Drug Enforcement Administration (DEA), will be submitting the following information collection request to the Office of Management and Budget (OMB) for review and approval in accordance with the Paperwork Reduction Act of 1995. This proposed information collection was previously published in the Federal Register on October 7, 2024, allowing for a 60-day comment period.
Full Text
<html>
<head>
<title>Federal Register, Volume 89 Issue 239 (Thursday, December 12, 2024)</title>
</head>
<body><pre>
[Federal Register Volume 89, Number 239 (Thursday, December 12, 2024)]
[Notices]
[Pages 100536-100537]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2024-29122]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
[OMB Number 1117-0014]
Agency Information Collection Activities; Proposed eCollection
eComments Requested; Revision of a Previously Approved Collection;
Application for Registration and Application for Registration Renewal;
DEA Forms 224, 224A
AGENCY: Drug Enforcement Administration, Department of Justice.
ACTION: 30-Day Notice.
-----------------------------------------------------------------------
SUMMARY: The Department of Justice (DOJ), Drug Enforcement
Administration (DEA), will be submitting the following information
collection request to the Office of Management and Budget (OMB) for
review and approval in accordance with the Paperwork Reduction Act of
1995. This proposed information collection was previously published in
the Federal Register on October 7, 2024, allowing for a 60-day comment
period.
DATES: Comments are encouraged and will be accepted for 30 days until
January 13, 2025.
FOR FURTHER INFORMATION CONTACT: If you have comments especially on the
estimated public burden or associated response time, suggestions, or
need a copy of the proposed information collection instrument with
instructions or additional information, please contact Heather E.
Achbach, Regulatory Drafting and Policy Support Section, Drug
Enforcement Administration; Mailing Address: 8701 Morrissette Drive,
Springfield, Virginia 22152; Telephone: (571) 776-3882; Email:
<a href="/cdn-cgi/l/email-protection#37737276196765767753525619505841"><span class="__cf_email__" data-cfemail="3b7f7e7a156b697a7b5f5e5a155c544d">[email protected]</span></a> or <a href="/cdn-cgi/l/email-protection#3f775a5e4b575a4d117a117e5c575d5e5c577f5b5a5e11585049"><span class="__cf_email__" data-cfemail="38705d594c505d4a167d16795b505a595b50785c5d59165f574e">[email protected]</span></a>.
SUPPLEMENTARY INFORMATION: Written comments and suggestions from the
public and affected agencies concerning the proposed collection of
information are encouraged. Your comments should address one or more of
the following four points:
--Evaluate whether the proposed collection of information is necessary
for the proper performance of the functions of the agency, including
whether the information will have practical utility;
--Evaluate the accuracy of the agency's estimate of the burden of the
proposed collection of information, including the validity of the
methodology and assumptions used;
--Enhance the quality, utility, and clarity of the information to be
collected; and/or
--Minimize the burden of the collection of information on those who are
to respond, including through the use of appropriate automated,
electronic, mechanical, or other technological collection techniques or
other forms of information technology, e.g., permitting electronic
submission of responses.
Written comments and recommendations for this information
collection should be submitted within 30 days of the publication of
this notice on the following website <a href="http://www.reginfo.gov/public/do/PRAMain">www.reginfo.gov/public/do/PRAMain</a>.
Find this particular information collection by selecting ``Currently
under 30-day Review--Open for Public Comments'' or by using the search
function and entering either the title of the information collection or
the OMB Control Number 1117-0014. This information collection request
may be viewed at <a href="http://www.reginfo.gov">www.reginfo.gov</a>. Follow the instructions to view
Department of Justice, information collections currently under review
by OMB.
DOJ seeks PRA authorization for this information collection for
three (3) years. OMB authorization for an ICR cannot be for more than
three (3) years without renewal. The DOJ notes that information
collection requirements submitted to the OMB for existing ICRs receive
a month-to-month extension while they undergo review.
Overview of This Information Collection:
1. Type of Information Collection: Revision of a Previously
Approved Collection.
2. Title of the Form/Collection: Application for Registration and
Application for Registration Renewal.
3. Agency form number, if any, and the applicable component of the
Department of Justice sponsoring the collection: DEA Forms 224, 224A.
The applicable component within the Department of Justice is the Drug
Enforcement Administration, Diversion Control Division.
Affected public who will be asked or required to respond, as well
as a brief abstract:
Affected public (Primary): Business or other for-profit.
Affected public (Other): Not-for-profit institutions; Federal,
State, Local, and tribal governments.
Abstract: The Controlled Substances Act (CSA) (21 U.S.C. 801-971)
requires all persons that manufacture, distribute, dispense, conduct
research with, import, or export any controlled substance to obtain a
registration issued by the Attorney General. DEA would be revising the
proposed information collection instruments as statutorily mandated by
the Protecting Patient Access to Emergency Medications Act of 2017. DEA
would be creating a new business activity and adding it to forms DEA-
224 and DEA-224A to allow Emergency Medical Services agencies to
register as such, if authorized by state law. This new business
activity would allow EMS agencies to obtain a DEA registration that
will permit EMS agencies to deliver controlled substances to their
designated locations without obtaining a separate registration as a
Distributor. This registration would allow EMS personnel to administer
controlled substances outside the physical presence of a medical
director or authorizing medical professional in the course of providing
emergency medical services. Upon issuance of an EMS agency
registration, the EMS agency should use the online system to identify
all of the locations it intends to designate under the EMS agencies'
DEA
[[Page 100537]]
registration. This proposed collection would also allow EMS agencies to
choose the option of a single registration in each state where the EMS
agency operates. If the agency operates EMS facilities in multiple
states, the agency must have a separate registration in each state
where the agency operates.
4. Obligation to Respond: Required to Obtain or Retain Benefits.
5. Total Estimated Number of Respondents: 670,481.
6. Estimated Time per Respondent: 0.203029 hours.
7. Frequency: 1 per year.
8. Total Estimated Annual Time Burden: 136,366 hours.
9. Total Estimated Annual Other Costs Burden: $0.
If additional information is required, contact: Darwin Arceo,
Department Clearance Officer, Policy and Planning Staff, Justice
Management Division, United States Department of Justice, Two
Constitution Square, 145 N Street NE, 4W-218 Washington, DC 20530.
Dated: December 6, 2024.
Darwin Arceo,
Department Clearance Officer for PRA, U.S. Department of Justice.
[FR Doc. 2024-29122 Filed 12-11-24; 8:45 am]
BILLING CODE 4410-09-P
</pre><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script></body>
</html>This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.